Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Rheumatoid arthritis (RA) is a lifelong, debilitating disease which incredibly impacts a patient’s quality of life if not treated to the optimal target. The clinical response of tocilizumab, an interleukin-6 (IL-6) inhibitor, is associated with several gene polymorphisms, particularly targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Janahiraman, Sivakami, Too, Chun Lai, Lee, Kai Wei, Shahril, Nor Shuhaila, Leong, Chee Onn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323282/
https://www.ncbi.nlm.nih.gov/pubmed/35886067
http://dx.doi.org/10.3390/genes13071284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323282/
https://www.ncbi.nlm.nih.gov/pubmed/35886067
http://dx.doi.org/10.3390/genes13071284

Ejemplares similares